PENRYN SURGERY
SARACEN WAY, PENRYN
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 18 | 18 | 100.0% | |
| CKD 4 | 2008 | 153 | 185 | 82.7% | |
| CKD 5 | 2009 | 41 | 42 | 97.6% | |
| CKD 5 | 2010 | 44 | 48 | 91.7% | |
| CKD 5 | 2011 | 48 | 53 | 90.6% | |
| CKD 5 | 2012 | 50 | 57 | 87.7% | |
| CKD 5 | 2013 | 43 | 51 | 84.3% | |
| CKD003 | 2014 | 44 | 47 | 93.6% | |
| CKD003 | 2015 | 39 | 44 | 88.6% | |
| NM84 | 2016 | 39 | 46 | 84.8% | |
| NM84 | 2017 | 34 | 47 | 72.3% | |
| NM84 | 2018 | 36 | 50 | 72.0% | |
| NM84 | 2019 | 28 | 38 | 73.7% | |
| NM84 | 2020 | 27 | 34 | 79.4% | |
| NM84 | 2022 | 22 | 29 | 75.9% |
